PGNY vs UNH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PGNY · Progyny$34.84 ▲ 1.37%
UNH · UnitedHealth$394.15 ▼ 0.40%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PGNY +47.5%
- UNH +25.1%
Head to head
| Metric | PGNY | UNH |
|---|---|---|
| Price | $34.84 | $394.15 |
| Change today | ▲ 1.37% | ▼ 0.40% |
| Market cap | $2.57B | $353.17B |
| Return, 3 months | +25.1% | -3.6% |
| Return, year to date | +35.7% | +21.0% |
| Return, 1 year | +55.7% | +24.0% |
| P/E (TTM) | 32.0 | 22.5 |
| P/B | 6.2 | 3.6 |
| P/E percentile vs own 5y | 16th | 40th |
| Dividend yield | – | 2.30% |
| Revenue growth (YoY, latest qtr) | +5.3% | -0.4% |
| Net profit growth (YoY) | +63.9% | +69.1% |
| Gross margin | 24.6% | 19.8% |
| Operating margin | 8.6% | 5.3% |
| Net margin | 6.0% | 3.5% |
| Return on equity | 16.2% | 15.9% |
| Analyst target vs. price | -3.5% | +22.5% |
| Analyst buy share | 75% | 82% |
| RSI (14) | 80 | 46 |
| 30-day volatility | 49.5% | 27.8% |
| Max drawdown, 1 year | -42.6% | -28.6% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UNH is the largest of the group by market value.
- PGNY has returned the most over the past year.
- UNH carries the lowest trailing P/E.
- PGNY is growing revenue fastest.
- PGNY keeps the most profit per dollar of sales.
- UNH has been the calmest stock over the last 30 days.